| KOTAK MANUFACTURE IN INDIA FUND
An open ended equity scheme following manufacturing theme
| KOTAK MANUFACTURE IN INDIA FUND
An open ended equity scheme following manufacturing theme

      

      
Investment Objective

The scheme shall seek to generate capital appreciation by investing in a diversified portfolio of companies that follow the manufacturing theme. However, there is no assurance that the objective of the Scheme will be realized.

The scheme shall seek to generate capital appreciation by investing in a diversified portfolio of companies that follow the manufacturing theme. However, there is no assurance that the objective of the Scheme will be realized.

Issuer/Instrument % to Net
Assets

Equity & Equity related
Pharmaceuticals and Biotechnology 17.37
Sun Pharmaceuticals Industries Ltd. 5.06
Dr Reddys Laboratories Ltd. 2.93
Zydus Lifesciences Limited 2.53
Biocon Ltd. 2.28
Cipla Ltd. 2.10
GlaxoSmithKline Pharmaceuticals Ltd. 1.09
Emcure Pharmaceuticals Limited 0.83
Ipca Laboratories Ltd. 0.55
Petroleum Products 11.92
Reliance Industries Ltd. 4.49
Bharat Petroleum Corporation Ltd. 2.84
Hindustan Petroleum Corporation Ltd 2.83
Indian Oil Corporation Ltd 1.76
Automobiles 11.30
Tata Motors Ltd. 2.98
Hero MotoCorp Ltd. 2.92
Maruti Suzuki India Limited 1.97
Mahindra & Mahindra Ltd. 1.95
Eicher Motors Ltd. 1.48
Auto Components 11.01
Bosch Ltd. 2.19
Bharat Forge Ltd. 1.92
Samvardhana Motherson International Limited 1.78
Exide Industries Ltd 1.56
Sansera Engineering Ltd. 1.35
Apollo Tyres Ltd. 0.92
Schaeffler India Ltd 0.89
JK Tyre & Industries Ltd. 0.40
Industrial Manufacturing 6.41
Dee Development Engineeers Ltd 1.99
Kaynes Technology India Ltd. 1.99
Jyoti CNC Automation Ltd 1.25
JNK India Limited 1.11
Honeywell Automation India Ltd. 0.07
Industrial Products 5.45
Cummins India Ltd. 2.04
Carborundum Universal Ltd. 1.75
AIA Engineering Limited. 1.23
Happy Forgings Ltd 0.43
Cement and Cement Products 4.36
Ambuja Cements Ltd. 2.45
Ultratech Cement Ltd. 1.91
Non - Ferrous Metals 3.65
Hindalco Industries Ltd 2.78
National Aluminium Company Ltd 0.87
Consumer Durables 3.61
Voltas Ltd. 1.35
V-Guard Industries Ltd. 1.18
Amber Enterprises India Ltd. 0.71
Cello World Ltd. 0.21
Dixon Technologies India Ltd. 0.16
Electrical Equipment 3.57
ABB India Ltd 2.44
Thermax Ltd. 1.13
Ferrous Metals 3.33
Tata Steel Ltd. 3.33
Construction 2.46
Larsen And Toubro Ltd. 2.46
Fertilizers and Agrochemicals 2.44
Coromandel International Ltd. 2.44
Chemicals and Petrochemicals 2.42
Solar Industries India Limited 1.13
SRF Ltd. 0.81
Tata Chemicals Ltd 0.48
Aerospace and Defense 2.41
Bharat Electronics Ltd. 2.41
Personal Products 1.26
Godrej Consumer Products Ltd. 1.26
Diversified 0.78
3M India Ltd. 0.78
Textiles and Apparels 0.55
Garware Technical Fibres Ltd. 0.55
Capital Markets 0.47
Premier Energies Limited 0.47
Equity & Equity related - Total 94.77
Mutual Fund Units
Kotak Liquid Direct Growth 0.33
Mutual Fund Units - Total 0.33
Triparty Repo 5.01
Net Current Assets/(Liabilities) -0.11
Grand Total 100.00



Systematic Investment Plan (SIP) If you had invested Rs 10,000 every month
Monthly SIP of (₹) 10000 Since Inception 1 year
Total amount invested (₹) 3,10,000 1,20,000
Total Value as on Aug 30, 2024 (₹) 4,44,376 1,41,899
Scheme Returns (%) 29.36 35.63
NIFTY INDIA MANUFACTURING TRI (%) 42.62 62.79
Alpha* -13.26 -27.17
NIFTY INDIA MANUFACTURING TRI (₹)# 5,14,214 1,57,468
Nifty 50 (₹)^ 4,19,608 1,41,155
Nifty 50 (%) 24.37 34.36

Scheme Inception : - February 22,2022. The returns are calculated by XIRR approach assuming investment of ₹10,000/- on the 1st working day of every month. XIRR helps in calculating return on investments given an initial and final value and a series of cash inflows and outflows and taking the time of investment into consideration. Since inception returns are assumed to be starting from the beginning of the subsequent month from the date of inception. The SIP Performance is for Regular Plan – Growth Option Different plans have different expense structure. # Benchmark; ^ Additional Benchmark. TRI – Total Return Index, In terms of para 6.14 of SEBI Master circular No. SEBI/HO/IMD/IMD-PoD-1/P/CIR/2024/90 dated June 27, 2024, the performance of the scheme is benchmarked to the Total Return variant (TRI) of the Benchmark Index instead of Price Return Variant (PRI). Alpha is difference of scheme return with benchmark return. *All payouts during the period have been reinvested in the units of the scheme at the then prevailing NAV. Source: ICRA MFI Explorer
Net Asset Value (NAV)
RegularDirect
Growth Rs19.2950Rs20.1096
IDCW Rs19.2948Rs20.1095
(as on August 30, 2024)

Available Plans/Options

A) Regular Plan B) Direct Plan
Options: Growth and Income Distribution cum capital withdrawal (IDCW) (Payout and Reinvestment)


Fund Manager* Mr. Harsha Upadhyaya & Mr. Abhishek Bisen
Benchmark Nifty India Manufacturing Index TRI
Allotment dateFebruary 22, 2022
AAUMRs2,458.66 crs
AUMRs2,520.00 crs
Folio count83,019

IDCW Frequency

Trustee's Discretion


Ratios
Portfolio Turnover19.03%
$Beta0.79
$Sharpe ##1.68
$Standard Deviation11.83%
(P/E) 27.20
P/BV 4.35
Source: $ ICRA MFI Explorer.

Minimum Investment Amount

Initial & Additional Investment
Rs100 and any amount thereafter
Systematic Investment Plan (SIP)
Rs 100 and any amount thereafter

Ideal Investments Horizon

• 5 years & above


Load Structure

Entry Load: Nil. (applicable for all plans)
Exit Load:
a) For redemption / switch out of upto 10% of the initial investment amount (limit) purchased or switched in within 1 year from the date of allotment: Nil.
b) If units redeemed or switched out are in excess of the limit within 1 year from the date of allotment: 1%
c) If units are redeemed or switched out on or after 1 year from the date of allotment: NIL
Units issued on reinvestment of IDCW shall not be subject to entry and exit load.


Total Expense Ratio**
Regular Plan: 1.95%
Direct Plan: 0.46%

Data as on 31st August, 2024 unless otherwise specified.

Folio count data as on 31st July 2024.

Fund


Benchmark
This product is suitable for investors who are seeking*:
  • Long-term capital growth
  • Investment equity and equity related securities across market capitalisation.

* Investors should consult their financial advisors if in doubt about whether the product is suitable for them.

The above risk-o—meter is based on the scheme portfolio as on 31st July, 2024. An addendum may be issued or updated on the website for new riskometer.


## Risk rate assumed to be 6.80% (FBIL Overnight MIBOR rate as on 30th Aug 2024). **Total Expense Ratio includes applicable B30 fee and GST
* For Fund Manager experience, please refer 'Our Fund Managers'
For scheme performance, please refer 'Scheme Performances'